287 related articles for article (PubMed ID: 35084720)
1. Stiff-person Syndrome and GAD Antibody-spectrum Disorders: GABAergic Neuronal Excitability, Immunopathogenesis and Update on Antibody Therapies.
Dalakas MC
Neurotherapeutics; 2022 Apr; 19(3):832-847. PubMed ID: 35084720
[TBL] [Abstract][Full Text] [Related]
2. GAD antibody-spectrum disorders: progress in clinical phenotypes, immunopathogenesis and therapeutic interventions.
Tsiortou P; Alexopoulos H; Dalakas MC
Ther Adv Neurol Disord; 2021; 14():17562864211003486. PubMed ID: 33854562
[TBL] [Abstract][Full Text] [Related]
3. The neurological syndromes associated with glutamic acid decarboxylase antibodies.
Baizabal-Carvallo JF
J Autoimmun; 2019 Jul; 101():35-47. PubMed ID: 31000408
[TBL] [Abstract][Full Text] [Related]
4. Neuronal surface and glutamic acid decarboxylase autoantibodies in Nonparaneoplastic stiff person syndrome.
Chang T; Alexopoulos H; McMenamin M; Carvajal-González A; Alexander SK; Deacon R; Erdelyi F; Szabó G; Lang B; Blaes F; Brown P; Vincent A
JAMA Neurol; 2013 Sep; 70(9):1140-9. PubMed ID: 23877118
[TBL] [Abstract][Full Text] [Related]
5. Therapies in Stiff-Person Syndrome: Advances and Future Prospects Based on Disease Pathophysiology.
Dalakas MC
Neurol Neuroimmunol Neuroinflamm; 2023 May; 10(3):. PubMed ID: 37059468
[TBL] [Abstract][Full Text] [Related]
6. Stiff person syndrome: quantification, specificity, and intrathecal synthesis of GAD65 antibodies.
Dalakas MC; Li M; Fujii M; Jacobowitz DM
Neurology; 2001 Sep; 57(5):780-4. PubMed ID: 11552003
[TBL] [Abstract][Full Text] [Related]
7. Stiff Person syndrome and other anti-GAD-associated neurologic disorders.
Dayalu P; Teener JW
Semin Neurol; 2012 Nov; 32(5):544-9. PubMed ID: 23677666
[TBL] [Abstract][Full Text] [Related]
8. Anti-glutamic acid decarboxylase antibodies in the serum and cerebrospinal fluid of patients with stiff-person syndrome: correlation with clinical severity.
Rakocevic G; Raju R; Dalakas MC
Arch Neurol; 2004 Jun; 61(6):902-4. PubMed ID: 15210528
[TBL] [Abstract][Full Text] [Related]
9. Stiff-person syndrome (SPS) and anti-GAD-related CNS degenerations: protean additions to the autoimmune central neuropathies.
Ali F; Rowley M; Jayakrishnan B; Teuber S; Gershwin ME; Mackay IR
J Autoimmun; 2011 Sep; 37(2):79-87. PubMed ID: 21680149
[TBL] [Abstract][Full Text] [Related]
10. The role of IVIg in the treatment of patients with stiff person syndrome and other neurological diseases associated with anti-GAD antibodies.
Dalakas MC
J Neurol; 2005 May; 252 Suppl 1():I19-25. PubMed ID: 15959668
[TBL] [Abstract][Full Text] [Related]
11. Immunology of stiff person syndrome and other GAD-associated neurological disorders.
Alexopoulos H; Dalakas MC
Expert Rev Clin Immunol; 2013 Nov; 9(11):1043-53. PubMed ID: 24168411
[TBL] [Abstract][Full Text] [Related]
12. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association.
Saiz A; Blanco Y; Sabater L; González F; Bataller L; Casamitjana R; Ramió-Torrentà L; Graus F
Brain; 2008 Oct; 131(Pt 10):2553-63. PubMed ID: 18687732
[TBL] [Abstract][Full Text] [Related]
13. [Stiff-person syndrome and other myelopathies constitute paraneoplastic neurological syndromes].
Ishii A
Brain Nerve; 2010 Apr; 62(4):377-85. PubMed ID: 20420178
[TBL] [Abstract][Full Text] [Related]
14. [Stiff-Person Syndrome and Related Autoantibodies].
Matsui N; Tanaka K; Kaji R
Brain Nerve; 2018 Apr; 70(4):357-362. PubMed ID: 29632283
[TBL] [Abstract][Full Text] [Related]
15. Neurological Syndromes Associated with Anti-GAD Antibodies.
Dade M; Berzero G; Izquierdo C; Giry M; Benazra M; Delattre JY; Psimaras D; Alentorn A
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32456344
[TBL] [Abstract][Full Text] [Related]
16. Stiff-person syndromes: motor cortex hyperexcitability correlates with anti-GAD autoimmunity.
Koerner C; Wieland B; Richter W; Meinck HM
Neurology; 2004 Apr; 62(8):1357-62. PubMed ID: 15111674
[TBL] [Abstract][Full Text] [Related]
17. Glutamic acid decarboxylase antibody-associated neurological syndromes: Clinical and antibody characteristics and therapy response.
Madlener M; Strippel C; Thaler FS; Doppler K; Wandinger KP; Lewerenz J; Ringelstein M; Roessling R; Menge T; Wickel J; Kellingshaus C; Mues S; Kraft A; Linsa A; Tauber SC; Berg FT; Gerner ST; Paliantonis A; Finke A; Priller J; Schirotzek I; Süße M; Sühs KW; Urbanek C; Senel M; Sommer C; Kuempfel T; Pruess H; Fink GR; Leypoldt F; Melzer N; Malter MP;
J Neurol Sci; 2023 Feb; 445():120540. PubMed ID: 36608627
[TBL] [Abstract][Full Text] [Related]
18. [Stiff-Person Syndrome].
Matsui N; Tanaka K; Izumi Y
Brain Nerve; 2023 Jun; 75(6):749-754. PubMed ID: 37287358
[TBL] [Abstract][Full Text] [Related]
19. A Case of Treatment Resistance and Complications in a Patient with Stiff Person Syndrome and Cerebellar Ataxia.
Jones LA; Baber W; Wardle M; Robertson NP; Morris HR; Church A; Llewelyn JG; Peall KJ
Tremor Other Hyperkinet Mov (N Y); 2019; 9():. PubMed ID: 31646058
[TBL] [Abstract][Full Text] [Related]
20. [Stiff-Person Syndrome].
Matsui N; Tanaka K; Izumi Y
Brain Nerve; 2021 May; 73(5):640-646. PubMed ID: 34006698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
